Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants

The COVID-19 pandemic, caused by the SARS-CoV-2 virus and its variants, has posed unprecedented challenges worldwide. Existing vaccines have limited effectiveness against SARS-CoV-2 variants. Therefore, novel vaccines to match mutated viral lineages by providing long-term protective immunity are urg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Guochao, Lau, Hungyan, Liu, Zhongqiu, Li, Chinyu, Xu, Zeping, Qi, Xiaoxiao, Zhang, Yu, Feng, Qian, Li, Runze, Deng, Xinyu, Li, Yebo, Zhu, Qing, Zhu, Sisi, Zhou, Hua, Pan, Hudan, Fan, Xingxing, Li, Yongchao, Li, Dan, Chen, Liqing, Ke, Bixia, Cong, Zhe, Lv, Qi, Liu, Jiangning, Liang, Dan, Li, An’an, Hong, Wenshan, Bao, Linlin, Zhou, Feng, Gao, Hongbin, Liang, Shi, Huang, Bihong, Wu, Miaoli, Qin, Chuan, Ke, Changwen, Liu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734593/
https://www.ncbi.nlm.nih.gov/pubmed/36494863
http://dx.doi.org/10.1186/s12985-022-01940-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734593/
https://www.ncbi.nlm.nih.gov/pubmed/36494863
http://dx.doi.org/10.1186/s12985-022-01940-w

Ejemplares similares